From what I can see, it needs to go through another 2 x trial phases before it can be sold? Who are they going to distribute it to if that is the case?
How much will this cut manufacturing capacity of their other products?
Are they being paid up front to manufacture or is that a cost MGC have the bear?
Ann: MGC Pharma Signs Agreement Targeting Anti-Viral Treatments, page-19
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.73M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4408 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 1899 | 2 |
View Market Depth
| Last trade - 16.12pm 08/11/2024 (20 minute delay) ? |
| RGT (ASX) Chart |
Day chart unavailable